Filing Details
- Accession Number:
- 0001384101-25-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-03 16:30:54
- Reporting Period:
- 2025-02-27
- Filing Date:
- 2025-03-03
- Accepted Time:
- 2025-03-03 16:30:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1991536 | John Leite | 6000 Shoreline Court, Suite 300 South San Francisco CA 94080 | Chief Commercial Officer-Clia | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-27 | 11,006 | $0.00 | 84,816 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-02-27 | 5,746 | $33.84 | 79,070 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-02 | 7,650 | $34.76 | 71,420 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Footnotes
- Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 27, 2025, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein.
- Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale.
- The reporting person is reporting the withholding of 816, 501 and 6,333 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,606, 985 and 12,470 Restricted Stock Units, respectively, granted on September 1, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person.
Billionaire Hedge Funds
